92 related articles for article (PubMed ID: 14598357)
1. Effects of major liver resection, with or without recombinant bactericidal/permeability-increasing protein (rBPI21), on the angiogenic profile of patients with metastatic colorectal carcinoma.
Wu FP; Boelens PG; van Leeuwen PA; Hoekman K; Hansma AH; Wiezer MJ; Meijer C; Meijer S; Scotté M; Cuesta MA
J Surg Oncol; 2003 Nov; 84(3):137-42. PubMed ID: 14598357
[TBL] [Abstract][Full Text] [Related]
2. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
Yoon SS; Kim SH; Gonen M; Heffernan NM; Detwiller KY; Jarnagin WR; D'Angelica M; Blumgart LH; Tanabe KK; Dematteo RP
Ann Surg Oncol; 2006 Mar; 13(3):353-62. PubMed ID: 16474912
[TBL] [Abstract][Full Text] [Related]
3. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
[TBL] [Abstract][Full Text] [Related]
4. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery.
Kirman I; Belizon A; Balik E; Feingold D; Arnell T; Horst P; Kumara S; Cekic V; Jain S; Nasar A; Whelan RL
Eur J Surg Oncol; 2007 Dec; 33(10):1169-76. PubMed ID: 17512160
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors.
Miyashita M; Tajiri T; Yanagi K; Shimizu T; Futami R; Sasajima K; Tokunaga A
Hepatogastroenterology; 2003; 50(50):308-9. PubMed ID: 12749209
[TBL] [Abstract][Full Text] [Related]
6. VEGF and endostatin levels in wound fluid and plasma after breast surgery.
Wu FP; Hoekman K; Meijer S; Cuesta MA
Angiogenesis; 2003; 6(4):255-7. PubMed ID: 15166493
[TBL] [Abstract][Full Text] [Related]
7. Increased growth factor expression after hepatic and pancreatic resection.
Justinger C; Schlüter C; Oliviera-Frick V; Kopp B; Rubie C; Schilling MK
Oncol Rep; 2008 Dec; 20(6):1527-31. PubMed ID: 19020737
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
Uematsu S; Higashi T; Nouso K; Kariyama K; Nakamura S; Suzuki M; Nakatsukasa H; Kobayashi Y; Hanafusa T; Tsuji T; Shiratori Y
J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy.
Seko Y; Fukuda S; Nagai R
Clin Sci (Lond); 2004 May; 106(5):439-42. PubMed ID: 14965340
[TBL] [Abstract][Full Text] [Related]
12. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
de Jong KP; Hoedemakers RM; Fidler V; Bijzet J; Limburg PC; Peeters PM; de Vries EG; Slooff MJ
Scand J Gastroenterol; 2004 Nov; 39(11):1141-8. PubMed ID: 15545174
[TBL] [Abstract][Full Text] [Related]
13. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
14. The role of a protease inhibitor against hepatectomy.
Gotohda N; Iwagaki H; Ozaki M; Konishi M; Nakagohri T; Takahashi S; Yagi T; Kinoshita T; Tanaka N
Hepatogastroenterology; 2006; 53(67):115-9. PubMed ID: 16506388
[TBL] [Abstract][Full Text] [Related]
15. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
16. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
[TBL] [Abstract][Full Text] [Related]
17. Lowering homocysteine decreases levels and expression of VEGF(165) and endostatin.
Atta HM; El-Rehani MA; Raheim SA; Galal AM
J Surg Res; 2008 May; 146(2):202-10. PubMed ID: 17597160
[TBL] [Abstract][Full Text] [Related]
18. [Effects of Erbie San on Walker-256 liver cancer and adjustment to unbalance of VEGF/endostatin in rats].
Wang S; Xu X; Zhang W; Li A; Dong W
Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(1):89-91. PubMed ID: 19382459
[TBL] [Abstract][Full Text] [Related]
19. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]